Locations:
Search IconSearch

News & Insight

Abraham, MD
July 20, 2022/Cancer/News & Insight

Building Trust is a Matter of Life and Death

The cornerstone of a successful doctor-patient relationship

22-CNR-2977865-CQD-Hero-650×450
June 28, 2022/Cancer/News & Insight

The Subjective Nature of “Safe and Tolerable” Conclusions

Dr. Aaron Gerds argues for more balance in safety reporting

Magnetic resonance imaging (MRI) of the brain, brain tumor
October 28, 2021/Cancer/News & Insight

Cognitive Function Remains Stable Following Concurrent Temozolomide-based Chemoradiation Therapy in Low-Grade Gliomas

Study shows encouraging safety results in rare type of adult brain cancer

Ductal carcinoma (breast cancer) high grade.
October 27, 2021/Cancer/News & Insight

Biosignature Predicts Benefit of Adjuvant Radiotherapy in Patients With DCIS

Novel assay identifies women most likely to benefit

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

19-ORT-1123-Diagnostic-PET-CQD
October 26, 2021/Cancer/News & Insight

18F Fluciclovine PET CT Helps Distinguish Radiation Necrosis from Brain Tumor Progression

Study presented at ASTRO 2021 shows promise in patients treated with stereotactic radiosurgery

Brian Bolwell, MD
January 25, 2021/Cancer/News & Insight

The Cancer Center and Cleveland Clinic’s Centennial

Reflecting on our progress and potential

T-cells_650x450
January 21, 2021/Cancer/News & Insight

Managing CAR T-Cell Therapy Across Cancer Center Programs

Researching and operationalizing a new therapy

Covid-19 vaccine
January 19, 2021/Cancer/News & Insight

COVID-19 mRNA Vaccines: What Does This Mean for Cancer?

Insights from the Director of the Center for Immunotherapy and Precision Immuno-Oncology

BackPage 7 of 13Next

Advertisement

Ad